Archives
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
Cy5 amine (non-sulfonated): Technical Guide for Sensitive La
2026-06-15
Cy5 amine (non-sulfonated) solves the challenge of labeling biomolecules in workflows requiring bright, photostable dyes that are insoluble in water. It is suitable for protein, peptide, and polymer conjugation in fluorescence microscopy and flow cytometry, but should not be used for direct aqueous labeling or for diagnostic purposes.
-
IGF2BP2 Inhibition Disrupts Cell Cycle and Glycolysis in Ova
2026-06-15
This study identifies IGF2BP2 as a key m6A RNA modification reader upregulated in malignant ovarian epithelial cells. Through combined single-cell analysis and functional assays, the authors show that inhibiting IGF2BP2 impairs cell cycle progression and glycolytic metabolism, suggesting a potential therapeutic target for ovarian cancer.
-
Everolimus (RAD001): Deconstructing mTOR Inhibition Dynamics
2026-06-14
Explore the intricate dynamics of Everolimus (RAD001) as an mTOR pathway inhibitor, with an in-depth focus on its mechanistic nuance and the impact of assay selection in cancer research. This article uniquely bridges quantitative drug response metrics with practical guidance for experimental design.
-
PERK–JAK1–STAT3 Axis Drives Pyroptosis in Disc Degeneration
2026-06-13
This study uncovers how endoplasmic reticulum stress accelerates inflammatory cell death in nucleus pulposus cells via PERK-dependent JAK1–STAT3 signaling, directly linking ER stress to intervertebral disc degeneration. The findings clarify the molecular pathway connecting the unfolded protein response to pyroptosis, highlighting new potential therapeutic targets for mitigating disc inflammation and degeneration.
-
Protease Inhibitor Cocktail: Precision in Lipid Droplet Assa
2026-06-12
The Protease Inhibitor Cocktail (100X H₂O, EDTA Plus) from APExBIO delivers unmatched protein stability for lipid droplet metabolism studies, safeguarding labile complexes during extraction. Its broad-spectrum, ready-to-use formulation empowers high-fidelity workflows for advanced DFCP1-ATGL axis research and beyond.
-
Potassium Iodide in Immunotherapy: Protocols & Workflow Adva
2026-06-12
Potassium Iodide (KI) is pivotal for bridging classic thyroid protection with advanced immunotherapy and nanotechnology research. Learn how APExBIO’s high-purity KI enables reproducible results, robust protocol design, and effective troubleshooting in complex experimental systems.
-
Fingolimod (FTY720): Beyond Immunomodulation in Neuro-Oncolo
2026-06-11
Explore the multifaceted roles of Fingolimod (FTY720) as an immunomodulatory agent for MS and a neuroprotective modulator. This in-depth review uncovers its mechanistic innovations and translational opportunities in immune cell engineering.
-
PBS Liposomes: Precision Controls for Macrophage Depletion A
2026-06-11
PBS Liposomes provide the gold-standard inert control for macrophage depletion workflows, ensuring assay reproducibility and robust data interpretation. Learn how to implement, optimize, and troubleshoot these phosphate-buffered saline liposomes to distinguish genuine biological effects from delivery artifacts in complex in vivo studies.
-
Perphenazine: Mechanistic Insights and Experimental Guidance
2026-06-10
Explore the multifaceted mechanisms of Perphenazine, a potent dopamine D2 receptor antagonist, with a focus on mitochondria-mediated cell death and host-directed antibacterial activity. This article offers protocol guidance, unique mechanistic depth, and critical analysis for advanced neuropharmacology and immunology research.
-
Quercetin as a PI3K Inhibitor: Integrative Mechanisms and Cl
2026-06-10
Explore the multifaceted role of Quercetin as a PI3K inhibitor in cancer and neuroinflammation research. This article uniquely examines molecular mechanisms, translational assay design, and practical applications, providing advanced insight for scientific investigators.
-
HMGB1 as an Early Serum Biomarker for Diabetic Nephropathy
2026-06-09
A recent quantitative proteomics study identified HMGB1 as a promising serum biomarker for early monitoring of diabetic nephropathy (DN), addressing the limitations of current noninvasive diagnostic methods. The findings highlight the potential of HMGB1 for improved disease stratification and early intervention in DN progression.
-
Verteporfin (CL 318952): Workflow Enhancements in PDT & Auto
2026-06-09
Verteporfin (CL 318952) enables dual-action experimental workflows in photodynamic therapy and autophagy inhibition, broadening the toolkit for age-related macular degeneration and cancer research. This article delivers protocol optimizations, troubleshooting insights, and integrative analysis of recent senolytic discovery, ensuring robust experimental outcomes with APExBIO-supplied Verteporfin.
-
Bedaquiline: Diarylquinoline Antibiotic for Advanced Researc
2026-06-08
Bedaquiline stands at the intersection of antimicrobial and anticancer research, excelling as a diarylquinoline antibiotic against multi-drug resistant tuberculosis while uniquely targeting cancer stem cell metabolism. This article unpacks its experimental workflows, protocol optimization, and the latest insights from host-directed therapy research.
-
Catalpol’s Multi-Pathway Protection in Cardio-Cerebrovascula
2026-06-08
This comprehensive review elucidates catalpol’s multi-faceted protective actions against cardio-cerebrovascular diseases, highlighting its anti-inflammatory, anti-oxidant, and anti-apoptotic mechanisms. The study synthesizes preclinical evidence and mechanistic insights, positioning catalpol as a promising natural agent for cardiovascular research.
-
IWP-2: Precision Wnt Production Inhibition in Cancer Researc
2026-06-07
IWP-2 is a potent Wnt production inhibitor that empowers researchers to dissect Wnt/β-catenin pathway dynamics with unparalleled specificity. This article delivers actionable workflows, experimental tips, and troubleshooting strategies for deploying IWP-2 in advanced cancer and cell stress studies.